DNAmTLAA

1. Advanced liver fibrosis is associated with DNAmTLAA in humans (10% decrease; β = -0.10, 95% CI -0.13 to -0.07).

   “a 10% decrease in DNAmTLAA (β = -0.10, 95% CI: -0.13 to -0.07) compared those without fibrosis.”

   HumansMASLD; advanced fibrosis versus no fibrosis; adjusted for demographics and medication statusn = 325

   Association between advanced fibrosis and epigenetic age acceleration among individuals with MASLD

   Journal of gastroenterology·20 Nov 2024

More on Advanced liver fibrosis